Skip to content

SCHEDULE 13GAccepted Jul 8, 5:20 PM ET

Prelude Therapeutics Inc SCHEDULE 13G

Soleus Private Equity Fund III, L.P.

Accepted (ET)

5:20 PM

Jul 8, 2026

Filed

Jul 8, 2026

Documents

2

Size

57.7 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.